CoLAB AccelBio

📍 Cantanhede, Portugal🗓 Founded 2021👥 13 employees💰 Last funded 2023
Biotechnology Research🌐 accelbio.pt
Website LinkedIn
AccelBio is a collaborative laboratory that aims to be the bridge that brings biomedical science closer to the market. With a set of partners that cover all the necessary capacities and expertise to drive drug discovery. AccelBio selects fundamental research discoveries and cutting-edge technology platforms and tools and guides the transformation of breakthrough science into validated and investment-worthy assets. AccelBio bridges academic research groups and start-ups with industry-standard drug discovery capabilities - target validation, assay development, high-throughput screening, in silico modelling, medicinal chemistry, in vitro and in vivo testing, IP support and business development. Innovative platforms are also being developed within a well-defined R&I agenda that will further boost drug discovery. By providing these capacities and specialized expertise, AccelBio will de-risk drug discovery assets until they are ready to be out-licensed to industry or established as the foundation of new spin-off companies.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Portugal
1
Frequently asked questions
Who invested in CoLAB AccelBio?
CoLAB AccelBio has 1 investors on record on gritt.io, including 1 early-stage backers.
When did CoLAB AccelBio last raise funding?
The most recent investment in CoLAB AccelBio recorded on gritt.io was in 2023.
When was CoLAB AccelBio founded?
CoLAB AccelBio was founded in 2021.
What industry is CoLAB AccelBio in?
CoLAB AccelBio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is CoLAB AccelBio based?
CoLAB AccelBio is headquartered in Cantanhede, Portugal.